Mechanisms of hematopoietic stem cell mobilization: When innate immunity assails the cells that make blood and bone

Experimental Hematology

Volumn 34, Issue 8, 2006, Pages 996-1009

  Winkler, Ingrid G ^a   Lévesque, Jean Pierre ^a,b  

^a MATER MEDICAL RESEARCH INSTITUTE   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

1,1' [1,4 PHENYLENEBIS(METHYLENE)]BIS(1,4,8,11 TETRAAZACYCLOTETRADECANE); ALPHA4 INTEGRIN; CHEMOKINE RECEPTOR CXCR2; CHEMOKINE RECEPTOR CXCR4; CYTOKINE; DEFIBROTIDE; DEXTRAN SULFATE; ENDOTOXIN; FLT3 LIGAND; FLUOROURACIL; FUCOIDIN; GRANULOCYTE COLONY STIMULATING FACTOR RECEPTOR; INTERLEUKIN 3; INTERLEUKIN 8; INTERSTITIAL COLLAGENASE; NEUTROPHIL COLLAGENASE; PADGEM PROTEIN; PERTUSSIS TOXIN; POLYANION; POLYMETHACRYLIC ACID; STEM CELL FACTOR; STROMAL CELL DERIVED FACTOR 1; TISSUE INHIBITOR OF METALLOPROTEINASE; VASCULAR CELL ADHESION MOLECULE 1;

AMINO TERMINAL SEQUENCE; BONE MARROW CELL; BONE TURNOVER; CLINICAL TRIAL; CYTOKINE PRODUCTION; ENDOTHELIUM CELL; ENZYME SUBSTRATE; EXTRACELLULAR MATRIX; FETUS LIVER; GENE OVEREXPRESSION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOMODULATION; INNATE IMMUNITY; INTESTINE FLORA; LEUKOCYTE ACTIVATION; LYMPHOCYTE HOMING; LYMPHOCYTE MIGRATION; MOLECULAR INTERACTION; NONHUMAN; OSSIFICATION; OSTEOCLAST; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; REVIEW; STEM CELL MOBILIZATION; WILD TYPE;

ANIMALS; BONE MARROW CELLS; BONE REMODELING; CELL MOVEMENT; CHEMOKINES, CXC; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL MOBILIZATION; HUMANS; IMMUNITY, NATURAL; MATRIX METALLOPROTEINASE 9; NEUTROPHILS; OSTEOGENESIS; PROTO-ONCOGENE PROTEINS C-KIT; VASCULAR CELL ADHESION MOLECULE-1;

EID: 33746046377     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exphem.2006.04.005     Document Type: Review

References (163)

1. Abkowitz J.L., Robinson A.E., Kale S., Long M.W., and Chen J. Mobilization of hematopoietic stem cells during homeostasis and after cytokine exposure. Blood 102 (2003) 1249-1253
2. Wright D.E., Wagers A.J., Gulati A.P., Johnson F.L., and Weissman I.L. Physiological migration of hematopoietic stem and progenitor cells. Science 294 (2001) 1933-1936
3. To L.B., Haylock D.N., Simmons P.J., and Juttner C.A. The biology and clinical uses of blood stem cells. Blood 89 (1997) 2233-2258
4. Korbling M., and Anderlini P. Peripheral blood stem cell versus bone marrow allotransplantation: does the source of hematopoietic stem cells matter?. Blood 98 (2001) 2900-2908
5. + cells. Blood 84 (1994) 2930-2939
6. Demirer T., and Bensinger W.I. Optimization of peripheral blood stem cell collection. Curr Opin Hematol 2 (1995) 219-226
7. + cell dose in autologous peripheral-blood stem-cell transplantation. J Clin Oncol 18 (2000) 3319-3320
8. To L.B., Dyson P.G., and Juttner C.A. Cell-dose effect in circulating stem-cell autografting. Lancet 2 (1986) 404-405
9. Sheridan W.P., Begley C.G., To L.B., et al. Phase II study of autologous filgrastim (G-CSF)-mobilized peripheral blood progenitor cells to restore hemopoiesis after high-dose chemotherapy for lymphoid malignancies. Bone Marrow Transplant 14 (1994) 105-111
10. Brown R.A., Adkins D., Goodnough L.T., et al. Factors that influence the collection and engraftment of allogeneic peripheral-blood stem cells in patients with hematologic malignancies. J Clin Oncol 15 (1997) 3067-3074
11. Siena S., Schiavo R., Pedrazzoli P., and Carlo-Stella C. Therapeutic relevance of CD34 cell dose in blood cell transplantation for cancer therapy. J Clin Oncol 18 (2000) 1360-1377
12. +/kg: an analysis of variables concerning mobilisation and engraftment. Hematol J 1 (2000) 374-381
13. Roberts A.W., DeLuca E., Begley C.G., Basser R., Grigg A.P., and Metcalf D. Broad inter-individual variations in circulating progenitor cell numbers induced by granulocyte colony-stimulating factor therapy. Stem Cells 13 (1995) 512-516
14. Bensinger W., Appelbaum F., Rowley S., et al. Factors that influence collection and engraftment of autologous peripheral-blood stem cells. J Clin Oncol 13 (1995) 2547-2555
15. Mikkola H.K.A., Gekas C., Orkin S.H., and Dieterlen-Lievre F. Placenta as a site for hematopoietic stem cell development. Exp Hematol 33 (2005) 1048-1054
16. Tavian M., and Peault B. The changing cellular environments of hematopoiesis in human development in utero. Exp Hematol 33 (2005) 1062-1069
17. Schweitzer K.M., Drager A.M., van der Valk P., et al. Constitutive expression of E-selectin and vascular cell adhesion molecule-1 on endothelial cells of hematopoietic tissues. Am J Pathol 148 (1996) 165-175
18. Sipkins D.A., Wei X., Wu J.W., et al. In vivo imaging of specialized bone marrow endothelial microdomains for tumour engraftment. Nature 435 (2005) 969-973
19. Frenette P.S., Subbarao S., Mazo I.B., von Andrian U.H., and Wagner D.D. Endothelial selectins and vascular cell adhesion molecule-1 promote hematopoietic progenitor homing to bone marrow. Proc Natl Acad Sci U S A 95 (1998) 14423-14428
20. Lévesque J.P., Zannettino A.C., Pudney M., et al. PSGL-1-mediated adhesion of human hematopoietic progenitors to P-selectin results in suppression of hematopoiesis. Immunity 11 (1999) 369-378
21. Dimitroff C.J., Lee J.Y., Rafii S., Fuhlbrigge R.C., and Sackstein R. CD44 is a major E-selectin ligand on human hematopoietic progenitor cells. J Cell Biol 153 (2001) 1277-1286
22. Mazo I.B., Gutierrez-Ramos J.C., Frenette P.S., Hynes R.O., Wagner D.D., and von Andrian U.H. Hematopoietic progenitor cell rolling in bone marrow microvessels: parallel contributions by endothelial selectins and vascular cell adhesion molecule 1. J Exp Med 188 (1998) 465-474
23. Katayama Y., Hidalgo A., Chang J., Peired A., and Frenette P.S. CD44 is a physiological E-selectin ligand on neutrophils. J Exp Med 201 (2005) 1183-1189
24. Winkler I.G., Snapp K.R., Simmons P.J., and Lévesque J.-P. Adhesion to E-selectin promotes growth inhibition and apoptosis of human and murine hematopoietic progenitor cells independent of PSGL-1. Blood 103 (2004) 1685-1692
25. Lowe J.B. Glycosylation in the control of selectin counter-receptor structure and function. Immunol Rev 186 (2002) 19-36
26. Arroyo A.G., Taverna D., Whittaker C.A., et al. In vivo roles of integrins during leukocyte development and traffic: insights from the analysis of mice chimeric for alpha 5, alpha v, and alpha 4 integrins. J Immunol 165 (2000) 4667-4675
27. Vermeulen M., Le Pesteur F., Gagnerault M.C., Mary J.Y., Sainteny F., and Lepault F. Role of adhesion molecules in the homing and mobilization of murine hematopoietic stem and progenitor cells. Blood 92 (1998) 894-900
28. Zanjani E.D., Flake A.W., Almeida-Porada G., Tran N., and Papayannopoulou T. Homing of human cells in the fetal sheep model: modulation by antibodies activating or inhibiting very late activation antigen-4-dependent function. Blood 94 (1999) 2515-2522
29. Katayama Y., Hidalgo A., Peired A., and Frenette P.S. Integrin α4β7 and its counterreceptor MAdCAM-1 contribute to hematopoietic progenitor recruitment into bone marrow following transplantation. Blood 104 (2004) 2020-2026
30. Scott L.M., Priestley G.V., and Papayannopoulou T. Deletion of α4 integrins from adult hematopoietic cells reveals roles in homeostasis, regeneration, and homing. Mol Cell Biol 23 (2003) 9349-9360
31. Katayama Y., Hidalgo A., Furie B.C., Vestweber D., Furie B., and Frenette P.S. PSGL-1 participates in E-selectin-mediated progenitor homing to bone marrow: evidence for cooperation between E-selectin ligands and α4 integrin. Blood 102 (2003) 2060-2067
32. Bonig H., Priestley G.V., and Papayannopoulou T. Hierarchy of molecular pathway usage in bone marrow homing and its shift by cytokines. Blood 107 (2006) 79-86
33. Hidalgo A., Sanz-Rodriguez F., Rodriguez-Fernandez J.L., et al. Chemokine stromal cell-derived factor-1alpha modulates VLA-4 integrin-dependent adhesion to fibronectin and VCAM-1 on bone marrow hematopoietic progenitor cells. Exp Hematol 29 (2001) 345-355
34. + cells: role in transendothelial/stromal migration and engraftment of NOD/SCID mice. Blood 95 (2000) 3289-3296
35. Wright N., Hidalgo A., Rodriguez-Frade J.M., et al. The chemokine stromal cell-derived factor-1α modulates α4β7 integrin-mediated lymphocyte adhesion to mucosal addressin cell adhesion molecule-1 and fibronectin. J Immunol 168 (2002) 5268-5277
36. + hemopoietic progenitors. Blood 88 (1996) 1168-1176
37. Lévesque J.P., Leavesley D.I., Niutta S., Vadas M., and Simmons P.J. Cytokines increase human hemopoietic cell adhesiveness by activation of very late antigen (VLA)-4 and VLA-5 integrins. J Exp Med 181 (1995) 1805-1815
38. Cui L., Ramsfjell V., Borge O., Veiby O., Lok S., and Jacobsen S. Thrombopoietin promotes adhesion of primitive human hemopoietic cells to fibronectin and vascular cell adhesion molecule-1: role of activation of very late antigen (VLA)-4 and VLA-5. J Immunol 159 (1997) 1961-1969
39. Weimar I.S., Miranda N., Muller E.J., et al. Hepatocyte growth factor/scatter factor (HGF/SF) is produced by human bone marrow stromal cells and promotes proliferation, adhesion and survival of human hematopoietic progenitor cells (CD34+). Exp Hematol 26 (1998) 885-894
40. Solanilla A., Grosset C., Duchez P., et al. Flt3-ligand induces adhesion of haematopoietic progenitor cells via a very late antigen (VLA)-4- and VLA-5-dependent mechanism. Br J Haematol 120 (2003) 782-786
41. Ma Q., Jones D., Borghesani P.R., et al. Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and SDF-1-deficient mice. Proc Natl Acad Sci U S A 95 (1998) 9448-9453
42. Zou Y.R., Kottmann A.H., Kuroda M., Taniuchi I., and Littman D.R. Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development. Nature 393 (1998) 595-599
43. Ara T., Nakamura Y., Egawa T., et al. Impaired colonization of the gonads by primordial germ cells in mice lacking a chemokine, stromal cell-derived factor-1 (SDF-1). Proc Natl Acad Sci U S A 100 (2003) 5319-5323
44. -/- chimeric mice. Blood 107 (2006) 2243-2251
45. + cells across specialized and nonspecialized endothelium requires prior activation by growth factors and is mediated by PECAM-1 (CD31). Blood 91 (1998) 1196-1205
46. Peach R.J., Hollenbaugh D., Stamenkovic I., and Aruffo A. Identification of hyaluronic acid binding sites in the extracellular domain of CD44. J Cell Biol 122 (1993) 257-264
47. Simmons P.J., Lévesque J.P., and Zannettino A.C. Adhesion molecules in haemopoiesis. Baillieres Clin Haematol 10 (1997) 485-505
48. Lord B.I., Testa N.G., and Hendry J.H. The relative spatial distributions of CFUs and CFUc in the normal mouse femur. Blood 46 (1975) 65-72
49. Mason T.M., Lord B.I., and Hendry J.H. The development of spatial distributions of CFU-S and in-vitro CFC in femora of mice of different ages. Br J Haematol 73 (1989) 455-461
50. Nilsson S.K., Johnston H.M., and Coverdale J.A. Spatial localization of transplanted hemopoietic stem cells: inferences for the localization of stem cell niches. Blood 97 (2001) 2293-2299
51. Kiel M.J., Yilmaz H., Iwashita T., Yilmaz O.H., Terhorst C., and Morrison S.J. SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells. Cell 121 (2005) 1109-1121
52. Zhang J., Niu C., Ye L., et al. Identification of the haematopoietic stem cell niche and control of the niche size. Nature 425 (2003) 836-841
53. Calvi L.M., Adams G.B., Weibrecht K.W., et al. Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 425 (2003) 841-846
54. Visnjic D., Kalajzic Z., Rowe D.W., Katavic V., Lorenzo J., and Aguila H.L. Hematopoiesis is severely altered in mice with an induced osteoblast deficiency. Blood 103 (2004) 3258-3264
55. Adams G.B., Chabner K.T., Alley I.R., et al. Stem cell engraftment at the endosteal niche is specified by the calcium-sensing receptor. Nature 439 (2006) 599-603
56. Nilsson S.K., Johnston H.M., Whitty G.A., et al. Osteopontin, a key component of the hematopoietic stem cell niche and regulator of primitive hematopoietic progenitor cells. Blood 106 (2005) 1232-1239
57. Nilsson S.K., Haylock D.N., Johnston H.M., Occhiodoro T., Brown T.J., and Simmons P.J. Hyaluronan is synthesized by primitive hemopoietic cells, participates in their lodgment at the endosteum following transplantation, and is involved in the regulation of their proliferation and differentiation in vitro. Blood 101 (2003) 856-862
58. Charbord P., Oostendorp R., Pang W., et al. Comparative study of stromal cell lines derived from embryonic, fetal, and postnatal mouse blood-forming tissues. Exp Hematol 30 (2002) 1202-1210
59. Nakamura H., Kenmotsu S., Sakai H., and Ozawa H. Localization of CD44, the hyaluronate receptor, on the plasma membrane of osteocytes and osteoclasts in rat tibiae. Cell Tissue Res 280 (1995) 225-233
60. Driessen R.L., Johnston H.M., and Nilsson S.K. Membrane-bound stem cell factor is a key regulator in the initial lodgment of stem cells within the endosteal marrow region. Exp Hematol 31 (2003) 1284-1291
61. Hosokawa K., Arai F., and Suda T. N-cadherin induces hematopoietic stem cells in a quiescent state in the bone marrow niche. [abstract]. Blood 106 (2005) 141a
62. Stier S., Ko Y., Forkert R., et al. Osteopontin is a hematopoietic stem cell niche component that negatively regulates stem cell pool size. J Exp Med 201 (2005) 1781-1791
63. Pruijt J.F., Verzaal P., van Os R., et al. Neutrophils are indispensable for hematopoietic stem cell mobilization induced by interleukin-8 in mice. Proc Natl Acad Sci U S A 99 (2002) 6228-6233
64. T/CXCL2Δ4. Blood 103 (2004) 110-119
65. Liu F., Poursine-Laurent J., and Link D.C. Expression of the G-CSF receptor on hematopoietic progenitor cells is not required for their mobilization by G-CSF. Blood 95 (2000) 3025-3031
66. Barrett A.J., Longhurst P., Sneath P., and Watson J.G. Mobilization of CFU-C by exercise and ACTH induced stress in man. Exp Hematol 6 (1978) 590-594
67. Cline M.J., and Golde D.W. Mobilization of hematopoietic stem cells (CFU-C) into the peripheral blood of man by endotoxin. Exp Hematol 5 (1977) 186-190
68. van der Ham A.C., Benner R., and Vos O. Mobilization of B T lymphocytes and haemopoietic stem cells by polymethacrylic acid and dextran sulphate. Cell Tissue Kinet 10 (1977) 387-397
69. To L.B., Haylock D.N., Kimber R.J., and Juttner C.A. High levels of circulating haemopoietic stem cells in very early remission from acute non-lymphoblastic leukaemia and their collection and cryopreservation. Br J Haematol 58 (1984) 399-410
70. To L.B., Davy M.L., Haylock D.N., Dyson P.G., Thorp D., and Juttner C.A. Autotransplantation using peripheral blood stem cells mobilized by cyclophosphamide. Bone Marrow Transplant 4 (1989) 595-596
71. Pruijt J.F., Fibbe W.E., Laterveer L., et al. Prevention of interleukin-8-induced mobilization of hematopoietic progenitor cells in rhesus monkeys by inhibitory antibodies against the metalloproteinase gelatinase B (MMP-9). Proc Natl Acad Sci U S A 96 (1999) 10863-10868
72. King A.G., Horowitz D., Dillon S.B., et al. Rapid mobilization of murine hematopoietic stem cells with enhanced engraftment properties and evaluation of hematopoietic progenitor cell mobilization in rhesus monkeys by a single injection of SB-251353, a specific truncated form of the human CXC chemokine GROβ. Blood 97 (2001) 1534-1542
73. Molineux G., Pojda Z., and Dexter T.M. A comparison of hematopoiesis in normal and splenectomized mice treated with granulocyte colony-stimulating factor. Blood 75 (1990) 563-569
74. Sato N., Sawada K., Takahashi T.A., et al. A time course study for optimal harvest of peripheral blood progenitor cells by granulocyte colony-stimulating factor in healthy volunteers. Exp Hematol 22 (1994) 973-978
75. Glaspy J.A., Shpall E.J., LeMaistre C.F., et al. Peripheral blood progenitor cell mobilization using stem cell factor in combination with filgrastim in breast cancer patients. Blood 90 (1997) 2939-2951
76. Molineux G., Migdalska A., Szmitkowski M., Zsebo K., and Dexter T.M. The effects on hematopoiesis of recombinant stem cell factor (ligand for c-kit) administered in vivo to mice either alone or in combination with granulocyte colony-stimulating factor. Blood 78 (1991) 961-966
77. Molineux G., McCrea C., Yan X.Q., Kerzic P., and McNiece I. Flt-3 ligand synergizes with granulocyte colony-stimulating factor to increase neutrophil numbers and to mobilize peripheral blood stem cells with long-term repopulating potential. Blood 89 (1997) 3998-4004
78. Torii Y., Nitta Y., Akahori H., et al. Mobilization of primitive haemopoietic progenitor cells and stem cells with long-term repopulating ability into peripheral blood in mice by pegylated recombinant human megakaryocyte growth and development factor. Br J Haematol 103 (1998) 1172-1180
79. + cells. Bone Marrow Transplant 24 (1999) 25-28
80. Roberts A.W., Foote S., Alexander W.S., Scott C., Robb L., and Metcalf D. Genetic influences determining progenitor cell mobilization and leukocytosis induced by granulocyte colony-stimulating factor. Blood 89 (1997) 2736-2744
81. Kerst J., de Haas M., van der Schoot C., et al. Recombinant granulocyte colony-stimulating factor administration to healthy volunteers: induction of immunophenotypically and functionally altered neutrophils via an effect on myeloid progenitor cells. Blood 82 (1993) 3265-3272
82. de Haas M., Kerst J.M., van der Schoot C.E., et al. Granulocyte colony-stimulating factor administration to healthy volunteers: analysis of the immediate activating effects on circulating neutrophils. Blood 84 (1994) 3885-3894
83. Lévesque J.P., Takamatsu Y., Nilsson S.K., Haylock D.N., and Simmons P.J. Vascular cell adhesion molecule-1 (CD106) is cleaved by neutrophil proteases in the bone marrow following hematopoietic progenitor cell mobilization by granulocyte colony-stimulating factor. Blood 98 (2001) 1289-1297
84. Lévesque J.P., Hendy J., Takamatsu Y., Williams B., Winkler I.G., and Simmons P.J. Mobilization by either cyclophosphamide or granulocyte colony-stimulating factor transforms the bone marrow into a highly proteolytic environment. Exp Hematol 30 (2002) 430-439
85. Hirsch E., Iglesias A., Potocnik A.J., Hartmann U., and Fassler R. Impaired migration but not differentiation of haematopoietic stem cells in the absence of beta1 integrins. Nature 380 (1996) 171-175
86. Papayannopoulou T., Priestley G.V., Nakamoto B., Zafiropoulos V., and Scott L.M. Molecular pathways in bone marrow homing: dominant role of α4β1 over β2-integrins and selectins. Blood 98 (2001) 2403-2411
87. Papayannopoulou T., and Nakamoto B. Peripheralization of hemopoietic progenitors in primates treated with anti-VLA4 integrin. Proc Natl Acad Sci U S A 90 (1993) 9374-9378
88. Craddock C.F., Nakamoto B., Andrews R.G., Priestley G.V., and Papayannopoulou T. Antibodies to VLA4 integrin mobilize long-term repopulating cells and augment cytokine-induced mobilization in primates and mice. Blood 90 (1997) 4779-4788
89. Kikuta T., Shimazaki C., Ashihara E., et al. Mobilization of hematopoietic primitive and committed progenitor cells into blood in mice by anti-vascular adhesion molecule-1 antibody alone or in combination with granulocyte colony-stimulating factor. Exp Hematol 28 (2000) 311-317
90. Scott L.M., Priestley G.V., and Papayannopoulou T. Deletion of α4 integrins from adult hematopoietic cells reveals roles in homeostasis, regeneration, and homing. Mol Cell Biol 23 (2003) 9349-9360
91. Ulyanova T., Scott L.M., Priestley G.V., et al. VCAM-1 expression in adult hematopoietic and nonhematopoietic cells is controlled by tissue-inductive signals and reflects their developmental origin. Blood 106 (2005) 86-94
92. Lévesque J.P., Liu F., Simmons P.J., et al. Characterization of hematopoietic progenitor mobilization in protease-deficient mice. Blood 104 (2004) 65-72
93. Lévesque J.P., Hendy J., Takamatsu Y., Simmons P.J., and Bendall L.J. Disruption of the CXCR4/CXCL12 chemotactic interaction during hematopoietic stem cell mobilization induced by G-CSF or cyclophosphamide. J Clin Invest 111 (2003) 187-196
94. Petit I., Szyper-Kravitz M., Nagler A., et al. G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4. Nat Immunol 3 (2002) 687-694
95. Ponomaryov T., Peled A., Petit I., et al. Induction of the chemokine stromal-derived factor-1 following DNA damage improves human stem cell function. J Clin Invest 106 (2000) 1331-1339
96. Tokoyoda K., Egawa T., Sugiyama T., Choi B.-I., and Nagasawa T. Cellular niches controlling B lymphocyte behavior within bone marrow during development. Immunity 20 (2004) 707-718
97. Semerad C.L., Christopher M.J., Liu F., et al. G-CSF potently inhibits osteoblast activity and CXCL12 mRNA expression in the bone marrow. Blood 106 (2005) 3020-3027
98. Shen H., Cheng T., Olszak I., et al. CXCR-4 desensitization is associated with tissue localization of hemopoietic progenitor cells. J Immunol 166 (2001) 5027-5033
99. Broxmeyer H.E., Orschell C.M., Clapp D.W., et al. Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist. J Exp Med 201 (2005) 1307-1318
100. Hattori K., Heissig B., Tashiro K., et al. Plasma elevation of stromal cell-derived factor-1 induces mobilization of mature and immature hematopoietic progenitor and stem cells. Blood 97 (2001) 3354-3360
101. Papayannopoulou T., Priestley G.V., Bonig H., and Nakamoto B. The role of G-protein signaling in hematopoietic stem/progenitor cell mobilization. Blood 101 (2003) 4739-4747
102. Gu Y., Filippi M.D., Cancelas J.A., et al. Hematopoietic cell regulation by Rac1 and Rac2 guanosine triphosphatases. Science 302 (2003) 445-449
103. McQuibban G.A., Butler G.S., Gong J.H., et al. Matrix metalloproteinase activity inactivates the CXC chemokine stromal cell-derived factor-1. J Biol Chem 276 (2001) 43503-43508
104. Delgado M.B., Clark-Lewis I., Loetscher P., et al. Rapid inactivation of stromal cell-derived factor-1 by cathepsin G associated with lymphocytes. Eur J Immunol 31 (2001) 699-707
105. Valenzuela-Fernandez A., Planchenault T., Baleux F., et al. Leukocyte elastase negatively regulates stromal cell-derived factor-1 (SDF-1)/CXCR4 binding and functions by amino-terminal processing of SDF-1 and CXCR4. J Biol Chem 277 (2002) 15677-15689
106. Christopherson II K.W., Cooper S., and Broxmeyer H.E. Cell surface peptidase CD26/DPPIV mediates G-CSF mobilization of mouse progenitor cells. Blood 101 (2003) 4680-4686
107. -/- mice. Exp Hematol 31 (2003) 1126-1134
108. Bonig H., Priestley G.V., and Papayannopoulou T. Superior bone marrow homing of G-CSF mobilized hematopoietic progenitor cells-a home run. [abstract]. Blood 106 (2005) 142a
109. Simmons P.J., Leavesley D.I., Lévesque J.P., et al. The mobilization of primitive hemopoietic progenitors into the peripheral blood. Stem Cells 12 (1994) 187-201 discussion 201-182
110. Roberts M.M., Swart B.W., Simmons P.J., Basser R.L., Begley C.G., and To L.B. Prolonged release and c-kit expression of haemopoietic precursor cells mobilized by stem cell factor and granulocyte colony stimulating factor. Br J Haematol 104 (1999) 778-784
111. Papayannopoulou T., Priestley G.V., and Nakamoto B. Anti-VLA4/VCAM-1-induced mobilization requires cooperative signaling through the kit/mkit ligand pathway. Blood 91 (1998) 2231-2239
112. Lévesque J.P., Hendy J., Winkler I.G., Takamatsu Y., and Simmons P.J. Granulocyte colony-stimulating factor induces the release in the bone marrow of proteases that cleave c-KIT receptor (CD117) from the surface of hematopoietic progenitor cells. Exp Hematol 31 (2003) 109-117
113. Nakamura Y., Tajima F., Ishiga K., et al. Soluble c-kit receptor mobilizes hematopoietic stem cells to peripheral blood in mice. Exp Hematol 32 (2004) 390-396
114. d mice. Leukemia 5 (1991) 75-77
115. Kim C.H., and Broxmeyer H.E. In vitro behavior of hematopoietic progenitor cells under the influence of chemoattractants: stromal cell-derived factor-1, steel factor, and the bone marrow environment. Blood 91 (1998) 100-110
116. Heissig B., Hattori K., Dias S., et al. Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell 109 (2002) 625-637
117. + haematopoietic stem cells is associated with a functional inactivation of the integrin very late antigen 4. Br J Haematol 110 (2000) 71-81
118. Winkler I.G., Hendy J., Coughlin P., Horvath A., and Lévesque J.P. Serine protease inhibitors serpina1 and serpina3 are down-regulated in bone marrow during hematopoietic progenitor mobilization. J Exp Med 201 (2005) 1077-1088
119. van Pel M., van Os R., Velders G.A., et al. Serpina1 is a potent inhibitor of IL-8-induced hematopoietic stem cell mobilization. Proc Natl Acad Sci U S A 103 (2006) 1469-1474
120. Docherty A.J., Lyons A., Smith B.J., et al. Sequence of human tissue inhibitor of metalloproteinases and its identity to erythroid-potentiating activity. Nature 318 (1985) 66-69
121. Ogawa M., Kawamoto M., and Yamanaka N. Matrix metalloproteinase and tissue inhibitor of metalloproteinase in human bone marrow tissues-an immunohistochemical study. J Nippon Med Sch 67 (2000) 235-241
122. + cells into the peripheral blood in idiopathic myelofibrosis may be due to the action of a number of proteases. Blood 105 (2005) 4508-4515
123. Wright D.E., Cheshier S.H., Wagers A.J., Randall T.D., Christensen J.L., and Weissman I.L. Cyclophosphamide/granulocyte colony-stimulating factor causes selective mobilization of bone marrow hematopoietic stem cells into the blood after M phase of the cell cycle. Blood 97 (2001) 2278-2285
124. Psenak O., Sefc L., Sykora V., Chang K.T., and Necas E. Cytokine gene expression in regenerating haematopoietic tissues of mice after cyclophosphamide treatment. Acta Haematol 109 (2003) 68-75
125. Kang T., Yi J., Guo A., et al. Subcellular distribution and cytokine- and chemokine-regulated secretion of leukolysin/MT6-MMP/MMP-25 in neutrophils. J Biol Chem 276 (2001) 21960-21968
126. Velders G.A., van Os R., Hagoort H., et al. Reduced stem cell mobilization in mice receiving antibiotic modulation of the intestinal flora: involvement of endotoxins as cofactors in mobilization. Blood 103 (2004) 340-346
127. Ratajczak J., Reca R., Kucia M., et al. Mobilization studies in mice deficient in either C3 or C3a receptor (C3aR) reveal a novel role for complement in retention of hematopoietic stem/progenitor cells in bone marrow. Blood 103 (2004) 2071-2078
128. Honczarenko M., Ratajczak M.Z., Nicholson-Weller A., and Silberstein L.E. Complement C3a enhances CXCL12 (SDF-1)-mediated chemotaxis of bone marrow hematopoietic cells independently of C3a receptor. J Immunol 175 (2005) 3698-3706
129. Selleri C., Montuori N., Ricci P., et al. Involvement of the urokinase-type plasminogen activator receptor in hematopoietic stem cell mobilization. Blood 105 (2005) 2198-2205
130. Tjwa M., Moons L., Theunissen K., et al. Role of plasmin and uPAR in bone marrow HSC/HPC retention and mobilization. [abstract]. Blood 106 (2005) 142a
131. Zhu J., and Emerson S.G. A new bone to pick: osteoblasts and the haematopoietic stem-cell niche. Bioessays 26 (2004) 595-599
132. Visnjic D., Kalajzic I., Gronowicz G., et al. Conditional ablation of the osteoblast lineage in Col2.3Δtk transgenic mice. J Bone Miner Res 16 (2001) 2222-2231
133. Vial T., and Descotes J. Clinical toxicity of cytokines used as haemopoietic growth factors. Drug Saf 13 (1995) 371-406
134. Takamatsu Y., Simmons P.J., Moore R.J., Morris H.A., To L.B., and Lévesque J.P. Osteoclast-mediated bone resorption is stimulated during short-term administration of granulocyte colony-stimulating factor but is not responsible for hematopoietic progenitor cell mobilization. Blood 92 (1998) 3465-3473
135. Lévesque J.P., Winkler I.G., Sims N., Morris H.A., Simmons P.J., and Takamatsu Y. The inhibition of the osteoblast niche during hematopoietic stem cell mobilization is an indirect effect involving mature bone marrow leukocytes, IL6 and soluble IL6 receptor. [abstract]. Blood 106 (2005) 557a
136. Katayama Y., Battista M., Kao W.M., et al. Signals from the sympathetic nervous system regulate hematopoietic stem cell egress from bone marrow. Cell 124 (2006) 407-421
137. Liu F., Poursine-Laurent J., and Link D.C. The granulocyte colony-stimulating factor receptor is required for the mobilization of murine hematopoietic progenitors into peripheral blood by cyclophosphamide or interleukin-8 but not flt-3 ligand. Blood 90 (1997) 2522-2528
138. El Ouriaghli F., Fujiwara H., Melenhorst J.J., Sconocchia G., Hensel N., and Barrett A.J. Neutrophil elastase enzymatically antagonizes the in vitro action of G-CSF: implications for the regulation of granulopoiesis. Blood 101 (2003) 1752-1758
139. de Haan G., Ausema A., Wilkens M., Molineux G., and Dontje B. Efficient mobilization of haematopoietic progenitors after a single injection of pegylated recombinant human granulocyte colony-stimulating factor in mouse strains with distinct marrow-cell pool sizes. Br J Haematol 110 (2000) 638-646
140. van Der Auwera P., Platzer E., Xu Z.X., et al. Pharmacodynamics and pharmacokinetics of single doses of subcutaneous pegylated human G-CSF mutant (Ro 25-8315) in healthy volunteers: comparison with single and multiple daily doses of filgrastim. Am J Hematol 66 (2001) 245-251
141. Morris E.S., MacDonald K.P., and Hill G.R. Stem cell mobilization with G-CSF analogs: a rational approach to separate GVHD and GVL?. Blood 107 (2006) 3430-3435
142. Morris E.S., MacDonald K.P.A., Rowe V., et al. Donor treatment with pegylated G-CSF augments the generation of IL-10-producing regulatory T cells and promotes transplantation tolerance. Blood 103 (2004) 3573-3581
143. Morris E.S., MacDonald K.P.A., Rowe V., et al. NKT cell-dependent leukemia eradication following stem cell mobilization with potent G-CSF analogs. J Clin Invest 115 (2005) 3093-3103
144. Stiff P., Gingrich R., Luger S., et al. A randomized phase 2 study of PBPC mobilization by stem cell factor and filgrastim in heavily pretreated patients with Hodgkin's disease or non-Hodgkin's lymphoma. Bone Marrow Transplant 26 (2000) 471-481
145. To L.B., Bashford J., Durrant S., et al. Successful mobilization of peripheral blood stem cells after addition of ancestim (stem cell factor) in patients who had failed a prior mobilization with filgrastim (granulocyte colony-stimulating factor) alone or with chemotherapy plus filgrastim. Bone Marrow Transplant 31 (2003) 371-378
146. Frenette P.S., and Weiss L. Sulfated glycans induce rapid hematopoietic progenitor cell mobilization: evidence for selectin-dependent and independent mechanisms. Blood 96 (2000) 2460-2468
147. Carlo-Stella C., Di Nicola M., Longoni P., et al. Mobilization of primitive and committed hematopoietic progenitors in nonhuman primates treated with defibrotide and recombinant human granulocyte colony-stimulating factor. Exp Hematol 32 (2004) 68-75
148. Carlo-Stella C., Di Nicola M., Magni M., et al. Defibrotide in combination with granulocyte colony-stimulating factor significantly enhances the mobilization of primitive and committed peripheral blood progenitor cells in mice. Cancer Res 62 (2002) 6152-6157
149. Patankar M.S., Oehninger S., Barnett T., Williams R.L., and Clark G.F. A revised structure for fucoidan may explain some of its biological activities. J Biol Chem 268 (1993) 21770-21776
150. Sweeney E.A., Priestley G.V., Nakamoto B., Collins R.G., Beaudet A.L., and Papayannopoulou T. Mobilization of stem/progenitor cells by sulfated polysaccharides does not require selectin presence. Proc Natl Acad Sci U S A 97 (2000) 6544-6549
151. Pelus L.M., Bian H., Fukuda S., Wong D., Merzouk A., and Salari H. The CXCR4 agonist peptide, CTCE-0021, rapidly mobilizes polymorphonuclear neutrophils and hematopoietic progenitor cells into peripheral blood and synergizes with granulocyte colony-stimulating factor. Exp Hematol 33 (2005) 295-307
152. Perez L.E., Alpdogan O., Shieh J.H., et al. Increased plasma levels of stromal-derived factor-1 (SDF-1/CXCL12) enhance human thrombopoiesis and mobilize human colony-forming cells (CFC) in NOD/SCID mice. Exp Hematol 32 (2004) 300-307
153. + cells following administration of the CXCR4 antagonist AMD3100 to patients with multiple myeloma and non-Hodgkin's lymphoma. J Clin Oncol 22 (2004) 1095-1102
154. Liles W.C., Broxmeyer H.E., Rodger E., et al. Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonist. Blood 102 (2003) 2728-2730
155. Flomenberg N., Devine S.M., DiPersio J.F., et al. The use of AMD3100 plus G-CSF for autologous hematopoietic progenitor cell mobilization is superior to G-CSF alone. Blood 106 (2005) 1867-1874
156. Roberts A.W., and Metcalf D. Noncycling state of peripheral blood progenitor cells mobilized by granulocyte colony-stimulating factor and other cytokines. Blood 86 (1995) 1600-1605
157. Uchida N., He D., Friera A.M., et al. The unexpected G0/G1 cell cycle status of mobilized hematopoietic stem cells from peripheral blood. Blood 89 (1997) 465-472
158. Giet O., Huygen S., Beguin Y., and Gothot A. Cell cycle activation of hematopoietic progenitor cells increases very late antigen-5-mediated adhesion to fibronectin. Exp Hematol 29 (2001) 515-524
159. Giet O., Van Bockstaele D.R., Di Stefano I., et al. Increased binding and defective migration across fibronectin of cycling hematopoietic progenitor cells. Blood 99 (2002) 2023-2031
160. Huygen S., Giet O., Artisien V., Di Stefano I., Beguin Y., and Gothot A. Adhesion of synchronized human hematopoietic progenitor cells to fibronectin and vascular cell adhesion molecule-1 fluctuates reversibly during cell cycle transit in ex vivo culture. Blood 100 (2002) 2744-2752
161. + cells in non-obese diabetic/severe combined immune-deficient mice. Blood 92 (1998) 2641-2649
162. - cells fractionated on the basis of adhesion molecule expression and position in cell cycle. Blood 96 (2000) 1380-1387
163. Rao R.M., Betz T.V., Lamont D.J., et al. Elastase release by transmigrating neutrophils deactivates endothelial-bound SDF-1alpha and attenuates subsequent T lymphocyte transendothelial migration. J Exp Med 200 (2004) 713-724